Oric Pharmaceuticals Inc
F:4TZ
Oric Pharmaceuticals Inc
F:4TZ
Price:
10.91
EUR
0.74%
Market Closed
Market Cap:
€735.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Oric Pharmaceuticals Inc
F:4TZ
|
US |
|
B
|
Beryl 8 Plus PCL
SET:BE8
|
TH |
|
A
|
Aira Capital PCL
SET:AIRA
|
TH |
|
B
|
Boutique Newcity PCL
SET:BTNC
|
TH |
|
H
|
Henry Schein Inc
XMUN:HS2
|
US |
|
F
|
Frontline Plc
OSE:FRO
|
CY |
|
Compumedics Ltd
ASX:CMP
|
AU |
|
Tongcheng Travel Holdings Ltd
F:TEM
|
CN |
Intrinsic Value
Not Available for 4TZ
There is not enough data to reliably calculate the intrinsic value for Oric Pharmaceuticals Inc.
Do our valuations actually work? See backtest results .
Alternatives to 4TZ
Fundamental Analysis
What Oric Pharmaceuticals Does
ORIC Pharmaceuticals is a clinical-stage drug developer focused on medicines for cancer and other serious diseases. Its main job is to discover and test new small-molecule therapies that target the biological pathways tumors use to grow, survive treatment, and become resistant to existing drugs.
- Headquarters
- United States of America US
- Employees
- 104
- IPO date
- Apr 24, 2020
Financials
Efficiency
Earnings Waterfall
Oric Pharmaceuticals Inc
Oric Pharmaceuticals Inc
